How much funding has HAYA Therapeutics raised?

HAYA Therapeutics has raised $62.0M in total funding, most recently a Series A round.

When was HAYA Therapeutics founded?

HAYA Therapeutics was founded in 2019.

Where is HAYA Therapeutics headquartered?

HAYA Therapeutics is headquartered in Lausanne, Switzerland.

What industry is HAYA Therapeutics in?

HAYA Therapeutics operates in Biotech.

How many employees does HAYA Therapeutics have?

HAYA Therapeutics has 11-50 employees.

HAYA Therapeutics

Programming lasting health

Lausanne, Switzerland · Founded 2019 · $62.0M raised

Biotech

Headquarters: Lausanne
Employees: 11–50
Founded: 2019
Business Model: B2B

Website: hayatx.com
Total Funding: $62.0M
Last Round: $62.0M Series AMay 2025
Rounds: 1

About

HAYA Therapeutics is a precision medicine company developing RNA-guided programmable therapeutics that target the regulatory genome — the 98% of the genome that doesn't code for proteins — to reverse disease-driving cell states. The company's platform integrates multimodal functional genomics with proprietary computational tools to discover and drug long non-coding RNAs (lncRNAs) that causally drive fibrotic and other serious diseases.

Summary

HAYA Therapeutics is a Biotech company based in Lausanne, Switzerland, founded in 2019. It has raised $62.0M in total across 1 round, most recently a $62.0M Series A round in May 2025.

LinkedIn X (Twitter)